drugset / Trial / NCT07116564
Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries
Timeline
- Start
- 2025-08-20
- Primary completion
- 2026-08-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 200 g | — |
| Subject | Fentanyl | Other / unclassified | 1 ug/kg | — |
| Subject | Fentanyl | Other / unclassified | 2 ug/kg | — |
| Subject | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |
| Comparator | Nabuphine | Unknown | 0.1 mg/kg | — |
Indications
No indication recorded.